CASDIN CAPITAL, LLC Holdings
CASDIN CAPITAL, LLC is an investment fund managing more than 1.52B US dollars. The largest holdings include EQRx, BioLife Solutions and Sarepta Therapeutics. In Q3 2022 the fund bought assets of total value of 376.45M US dollars and sold assets of total value of 109.14M US dollars.
CASDIN CAPITAL, LLC portfolio value:
$1.52B
portfolio value
CASDIN CAPITAL, LLC quarter portfolio value change:
+23.23%
quarter
CASDIN CAPITAL, LLC 1 year portfolio value change:
-54.13%
1 year
CASDIN CAPITAL, LLC 3 years portfolio value change:
-185.61%
3 years
CASDIN CAPITAL, LLC 5 years portfolio value change:
-485.82%
5 years
CASDIN CAPITAL, LLC portfolio changes
| Period | Buy | Sel |
|---|---|---|
| Q1 2016 | 4990000 | 25565000 |
| Q2 2016 | 23592000 | 14403000 |
| Q3 2016 | 36834000 | 9628000 |
| Q4 2016 | 19973000 | 18479000 |
| Q1 2017 | 42248000 | 1858000 |
| Q2 2017 | 69570000 | 9117000 |
| Q3 2017 | 106937000 | 25293000 |
| Q4 2017 | 71052000 | 5169000 |
| Q1 2018 | 122135000 | 6395000 |
| Q2 2018 | 138608000 | 33975000 |
| Q3 2018 | 188461000 | 1511000 |
| Q4 2018 | -18750000 | 142356000 |
| Q1 2019 | 308302000 | 24781000 |
| Q2 2019 | 179447494 | 43079047 |
| Q3 2019 | 47627761 | 30183590 |
| Q4 2019 | 109765552 | 19517360 |
| Q1 2020 | 108460000 | 121315000 |
| Q2 2020 | 574023000 | 62838000 |
| Q3 2020 | 366846000 | 54069000 |
| Q4 2020 | 864175000 | 15706000 |
| Q1 2021 | 252248000 | 213686000 |
| Q2 2021 | 571890000 | 85136000 |
| Q3 2021 | 707997000 | 141116000 |
| Q4 2021 | 380592000 | 375343000 |
| Q1 2022 | 10519000 | 461999000 |
| Q2 2022 | -10334000 | 792189000 |
| Q3 2022 | 376450000 | 109141000 |
CASDIN CAPITAL, LLC 13F holdings
| Stock |
|---|
| Portfolio share: 12.85% Portfolio value: 195.66M Avg. open price: N/A Current price: $3.46 P/L: N/A N/A Q4 2021 |
| Portfolio share: 11.31% Portfolio value: 172.13M Avg. open price: $16.4 Current price: $18.9 P/L: +15.23% Bought +1.70% shares Q3 2021 |
| Portfolio share: 8.89% Portfolio value: 135.41M Avg. open price: $103.97 Current price: $122.96 P/L: +18.26% Bought +88.46% shares Q3 2022 |
| Portfolio share: 8.52% Portfolio value: 129.70M Avg. open price: $108.85 Current price: $226.4 P/L: +107.99% Sold -19.50% shares Q3 2022 |
| Portfolio share: 7.36% Portfolio value: 112.01M Avg. open price: $67.48 Current price: $50.19 P/L: -25.63% Bought +47.83% shares Q3 2022 |
| Portfolio share: 7.17% Portfolio value: 109.17M Avg. open price: $37.94 Current price: $21.42 P/L: -43.54% Bought +1.27% shares Q3 2022 |
| Portfolio share: 6.88% Portfolio value: 104.76M Avg. open price: $25.46 Current price: $18.36 P/L: -27.89% Bought +15.11% shares Q3 2022 |
| Portfolio share: 4.83% Portfolio value: 73.45M Avg. open price: $204.44 Current price: $213.86 P/L: +4.61% N/A Q3 2022 |
| Portfolio share: 4.58% Portfolio value: 69.78M Avg. open price: N/A Current price: $5.43 P/L: N/A Sold -23.16% shares Q3 2022 |
| Portfolio share: 3.27% Portfolio value: 49.74M Avg. open price: $35.47 Current price: $24.32 P/L: -31.44% Bought +6.43% shares Q3 2022 |
| Portfolio share: 3.02% Portfolio value: 45.94M Avg. open price: $17.6 Current price: $20.4 P/L: +15.89% Sold -2.38% shares Q3 2022 |
| Portfolio share: 2.40% Portfolio value: 36.55M Avg. open price: $4.52 Current price: $2.7 P/L: -40.27% Bought +1.74% shares Q3 2022 |
| Portfolio share: 2.08% Portfolio value: 31.71M Avg. open price: N/A Current price: $10.25 P/L: N/A N/A Q2 2021 |
| Portfolio share: 2.06% Portfolio value: 31.41M Avg. open price: $97.91 Current price: $45.55 P/L: -53.48% Bought +114.89% shares Q3 2022 |
| Portfolio share: 2.01% Portfolio value: 30.53M Avg. open price: $32.73 Current price: $30.94 P/L: -5.46% Sold -33.67% shares Q3 2022 |
| Portfolio share: 1.59% Portfolio value: 24.15M Avg. open price: N/A Current price: $2.4 P/L: N/A N/A Q3 2021 |
| Portfolio share: 1.16% Portfolio value: 17.62M Avg. open price: $81.64 Current price: $44.37 P/L: -45.65% Sold -1.33% shares Q3 2022 |
| Portfolio share: 1.15% Portfolio value: 17.46M Avg. open price: $67.13 Current price: $92.75 P/L: +38.16% Bought +157.73% shares Q3 2022 |
| Portfolio share: 1.08% Portfolio value: 16.50M Avg. open price: N/A Current price: $42.01 P/L: N/A N/A Q3 2022 |
| Portfolio share: 1.07% Portfolio value: 16.31M Avg. open price: $10.65 Current price: $11.91 P/L: +11.78% Bought +120.00% shares Q3 2022 |
| Portfolio share: 1.03% Portfolio value: 15.66M Avg. open price: N/A Current price: $17 P/L: N/A N/A Q3 2022 |
| Portfolio share: 0.95% Portfolio value: 14.42M Avg. open price: $3.07 Current price: $0.38 P/L: -87.51% Bought +228.75% shares Q2 2022 |
| Portfolio share: 0.84% Portfolio value: 12.86M Avg. open price: $34.29 Current price: $27.74 P/L: -19.10% Sold -27.00% shares Q3 2022 |
| Portfolio share: 0.68% Portfolio value: 10.40M Avg. open price: N/A Current price: $2.42 P/L: N/A N/A Q3 2021 |
| Portfolio share: 0.59% Portfolio value: 8.94M Avg. open price: N/A Current price: $15.36 P/L: N/A N/A Q1 2022 |
| Portfolio share: 0.58% Portfolio value: 8.89M Avg. open price: N/A Current price: $39.53 P/L: N/A N/A Q3 2022 |
| Portfolio share: 0.46% Portfolio value: 6.98M Avg. open price: $67.13 Current price: $92.75 P/L: +38.16% N/A Q3 2022 |
| Portfolio share: 0.30% Portfolio value: 4.63M Avg. open price: N/A Current price: $36.66 P/L: N/A N/A Q2 2022 |
| Portfolio share: 0.27% Portfolio value: 4.17M Avg. open price: N/A Current price: $9.43 P/L: N/A Sold -46.83% shares Q2 2022 |
| Portfolio share: 0.25% Portfolio value: 3.84M Avg. open price: N/A Current price: $175.93 P/L: N/A N/A Q3 2022 |
| Portfolio share: 0.22% Portfolio value: 3.36M Avg. open price: $3.82 Current price: $1.92 P/L: -49.74% Bought +55.45% shares Q3 2022 |
| Portfolio share: 0.18% Portfolio value: 2.77M Avg. open price: $24.28 Current price: $2.73 P/L: -88.76% Bought +8.43% shares Q3 2022 |
| Portfolio share: 0.15% Portfolio value: 2.26M Avg. open price: N/A Current price: $28.31 P/L: N/A N/A Q3 2022 |
| Portfolio share: 0.12% Portfolio value: 1.75M Avg. open price: N/A Current price: $5.51 P/L: N/A Sold -67.78% shares Q3 2022 |
| Portfolio share: 0.03% Portfolio value: 451K Avg. open price: $11.29 Current price: $1.24 P/L: -89.02% Sold -86.75% shares Q3 2022 |
| Portfolio share: 0.03% Portfolio value: 415K Avg. open price: N/A Current price: $1.77 P/L: N/A Sold -78.77% shares Q2 2022 |
| Portfolio share: 0.03% Portfolio value: 411K Avg. open price: N/A Current price: $1.49 P/L: N/A N/A Q4 2021 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $9.89 P/L: N/A Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $51.95 P/L: N/A Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $42.14 Current price: $23.17 P/L: -45.02% Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $226.95 P/L: N/A Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $25.01 Current price: $4.02 P/L: -83.93% Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $37.29 Current price: $68.49 P/L: +83.68% Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $9.8 Current price: $3.54 P/L: -63.86% Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $0.61 P/L: N/A Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $51.3 Current price: $29.8 P/L: -41.91% Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $7.69 P/L: N/A Sold -100.00% shares Q3 2022 |
Showing TOP 47 CASDIN CAPITAL's 13F holdings.
Frequently Asked Questions (FAQ)
What is the biggest position of CASDIN CAPITAL, LLC?
The biggest position of the CASDIN CAPITAL, LLC is EQRx, Inc. (EQRX) with 12.85% portfolio share worth of 195.66M US dollars.
Top 5 CASDIN CAPITAL's holdings represent 48.93% of the portfolio:
- EQRx, Inc. (EQRX) – 12.85%
- BioLife Solutions, Inc. (BLFS) – 11.31%
- Sarepta Therapeutics, Inc. (SRPT) – 8.9%
- Alnylam Pharmaceuticals, Inc. (ALNY) – 8.52%
- Blueprint Medicines Corporation (BPMC) – 7.36%
Who is the portfolio manager of CASDIN CAPITAL, LLC?
The portfolio manager of the CASDIN CAPITAL, LLC is .
What is the total asset value of the CASDIN CAPITAL, LLC portfolio?
CASDIN CAPITAL, LLC total asset value (portfolio value) is 1.52B US dollars.
Who is ?
is the portfolio manager of the CASDIN CAPITAL, LLC.
What is (CASDIN CAPITAL, LLC) fund performance?
CASDIN CAPITAL's quarterly performance is +23.23%, annualy -54.13%. In the past 3 years, the value of 's portfolio has decreased by -186%. In the past 5 years, the value of the portfolio has decreased by -486%.
What is the CASDIN CAPITAL, LLC CIK?
CASDIN CAPITAL's Central Index Key is 0001534261 .